Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Fibrocell Science, Inc. | c17118e10vq.htm |
EX-32.2 - EXHIBIT 32.2 - Fibrocell Science, Inc. | c17118exv32w2.htm |
EX-31.1 - EXHIBIT 31.1 - Fibrocell Science, Inc. | c17118exv31w1.htm |
EX-31.2 - EXHIBIT 31.2 - Fibrocell Science, Inc. | c17118exv31w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2011 of
Fibrocell Science, Inc. (the Company) as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, David Pernock, Chief Executive Officer of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
| The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C 78m or 78o(d)); and |
| The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. |
Date: May 13, 2011 | By: | /s/ David Pernock | ||
David Pernock | ||||
Chief Executive Officer |
A signed original of this written statement required by Section 906 has been provided to Fibrocell
Science, Inc. and will be retained by Fibrocell Science, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.